Pharm of Drugs in Upper GI Disease Flashcards

1
Q

How is H+ secreted into the lumen of the stomach?

A

Via a H/K ATPase (H out, K in)

Constitutive activation via histamine release from enterochromaffin-like cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prostaglandin E2

A

Mediates mucus and bicarb secretion from mucus cells

Via EP receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 general ways to treat acid-related disorders

A

Neutralize or reduce gastric levels of H+/ H pylori

Strengthen/enhance protective factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

5 options for acid neutralizing/lowering drugs

3 main ones, 2 others

A
Antacids
Histamine H2 receptor antagonists
Proton pump inhibitors
Antimuscarinics
Gastrin receptor antagonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antacids

3 examples and MOA

A

Al(OH)3, Mg(OH)2, CaCO3
Direct neutralization of already secreted stomach acid
Increased gastric pH
No receptor interaction (direct chemical interaction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacokinetics of antacids

A

Counter ions (Al, Ca, Mg) are poorly absorbed
They may chelate other drugs, affecting their absorption
Altered pH may affect drug absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications for antacids

A

Heartburn/mild GERD

Dyspepsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Side effects from antacids

A

Carbonate based salts: belching (CO2 is produced)
Ca: hypercalcemia
Al: constipation, hypophosphatemia (impaired absorption)
Mg: diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

H2 receptor antagonists

A

Competitive, selective block of histamine H2 receptors
The -tidine drugs (ranitidine)
Reduced (but not eliminated) acid secretion
ACh and gastrin pathways in response to a meal are still active
Most effective in reduction of nocturnal acid secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetics in H2 receptor antagonists

A

Oral, intramuscular, and intravenous formulations
Bioavailability is 50%, need a twice daily administration (except nizatidine - oral, minimal 1st pass metabolism)
Renal elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indications for H2 receptor antagonists

A

GERD
Peptic ulcer disease
Dyspepsia
Prevention of bleeding from stress-related gastritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Some common and some rare side effects from H2 receptor antagonists

A

Common: diarrhea (or constipation), headache, drowsiness/fatigue, muscle pain
Rare: confusion/agitation, delirum/hallucinations, slurred speech

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Proton pump inhibitors

A

The -prazole drugs (ex: omeprazole)
Irreversible inactivation of proton pump common to ALL triggers of gastric acid secretion (inhibits the H/K ATPase)
Restoration of function requires new proton pump synthesis (takes 18-24 hours)
Relatively selective for parietal cell proton pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacokinetics of PPIs

A

Parietal cell access requires systemic absorption (oral formulations require enteric coating)
Prodrug molecules activated by acid (best if taken within 30-60 mins of meal)
Drug interactions: altered pH (reduced absorption of some drugs), competition for certain cytochrom P450 enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications for a PPI

A

Gastric/duodenal ulcer (H pylori associated or NSAID induced)
GERD
Prevention of bleeding from stress-related gastritis
Gastric hypersecretory conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Common side effects of PPIs

A
Generally well-tolerated
Nausea
Diarrhea (or constipation)
Abdominal pain
Flatulence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Antimuscarinics

A

Work on food induced pathways
Ex: pirenzipine
Utile and effective, but side effects!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Gastrin receptor antagonists

A

Ex: proglumide
Work on food induced pathways
Pathway inhibited at pH < 2.5 (won’t give you tangible benefits)
Blocks the CCK2/B receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment for H pylori

A

PPI and two antibiotics and 14 days (triple therapy)
Clarithromycin and amoxicillin or metronsazole
Or PPI alone for 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Misoprostol

A

Prostaglandin E1 analogue (emulates endogenous PGE2)

Direct effects on parietal cells (inhibitory) or mucus cells (stimulatory)

21
Q

Pharmacokinetics of misoprostol

A

Short half-life
Frequent dosing
No impact on cytochrome P450

22
Q

Indication for misoprostol

A

NSAID-induced ulcers

23
Q

Contraindication of misoprostol

A

Pregnancy

Its a strong uterine stimulant so there is a huge uterine stimulant

24
Q

Side effects from misoprostol

A

Diarrhea
Abdominal cramping
Uterine contraction
All because prostaglandin E1/E2 to stimulate GI/uterine smooth muscle

25
Sucralfate
``` Al(OH)3-sucrose sulfate complex Acid release anionic sulfated sucrose Binds to charged proteins in ulcer Viscous, sticky, protective barrier Indirect stimulation of PGE2 production ```
26
Pharmacokinetics of sucralfate
Localized action, minimal systemic absorption Short effect (6 hours) Take on empty stomach
27
Indications for sucralfate
Gastric and duodenal ulcer
28
Side effects of sucralfate
Al-induced constipation | May reduce absorption of some other drugs (Direct binding, or impaired membrane crossing)
29
Bismuth subsalicylate
Coat ulcers to form a physical protective barrier Increased PGE2, HCO3 and mucus production Antimicrobial against H pylori Reduces stool frequency
30
Pharmacokinetics of bismuth subsalicylate
Dissociated in stomach, acts locally | Only salicylate substantially absorbed
31
Indications for bismuth subsalicylate
Adjuvant to triple therapy for H pylori-induced ulcers | Acute diarrhea
32
Contraindications of bismuth subsalicylate
Children with viral infections (Reye's syndrome) | Allergies to ASA
33
Side effects as bismuth subsalicylate
Black stool (reaction with hydrogen sulfide in colon, may be confused with GI bleeding) Blackening of tongue Constipation
34
Prokinetic drugs
Ex: metoclopramide and domperidone Both dopamine D2 receptor antagonists Metoclopromaide has additional activity as agonist of serotonin receptors Relieve basal dopamine inhibition of upper GI tract, stimulating peristalsis and facilitating gastric emptying Move things along the tract faster (less material in the GI tract that can splash up into the esophagus)
35
Pharmacokinetics of prokinetics drugs
Metoclopromide is available in oral and parenteral formulations Domperiodone has greater first-pass metabolism Short duration of action Hepatic metabolism
36
Indications of prokinetic drugs
GERD Impaired gastric emptying Nausea and vomiting Postpartum lactation stimulation
37
Contraindications of prokinetic drugs
Situations where GI motility is harmful
38
Side effects of prokinetic drugs
GI crampings Diarrhea Hyperprolactinemia Metoclopromide (not domperidone) crosses BBB
39
Anti-emetic pharmacology
Based on receptor expression in brainstem vomiting center and/or chemoreceptor trigger zone Ex: Ondansetron, Dimenhydrinate, Scopolamine
40
Ondansetron
Antagonist of serotonin 5-HT3 receptors | Vomiting center, chemoreceptor trigger zone, vagal afferents
41
Indications for ondansetron
Chemotherapy-induced nausea and vomiting | Postoperative and postradiation nausea and vomiting
42
Side effects for Ondansetron
Headache Dizziness Constipation
43
Dimenhydrinate
Antagonist of histamine H1 receptors (some anticholinergic activity) Relatively weak anti-emetic activity (can be used as adjuvant)
44
Indications for dimenhydrinate
Motion sickness (prevention or treatment)
45
Side effects of dimenhydrinate
Dizziness Sedation/drowsiness Dry mouth Urinary retention
46
Scopolamine
Antagonist of muscarinic receptors Comparable efficacy to dimenhydrinate Best administered as transdermal patch
47
Indication for scopolamine
Motion sickness (prevention and treatments)
48
Side effects of scopolamine
Antagonist of muscarinic receptors when given orally Comparable efficacy to dimenhydrinate Best administered as transdermal patch